EP2203462
Núkleósíð-fosfóramídat-forlyf
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
26.3.2008EP published:
21.5.2014EP application number:
08732818.3
EP translation filed:
10.7.2014Grant published:
15.8.2014EPO information:
European Patent Register
Max expiry date:
25.3.2028Expiry date:
25.3.2027Next due date:
31.3.2027
Title:
NUCLEOSIDE PHOSPHORAMIDATE PRODRUGS
Timeline
Owner
Name:
Gilead Pharmasset LLCAddress:
c/o Gilead Sciences, Inc., 333 Lakeside Drive, 94404, Foster City, CA, US
Inventor
Name:
SOFIA, Michael, JosephAddress:
Doylestown, PA, US
Name:
DU, JinfaAddress:
New Hope, PA, US
Name:
WANG, PeiyuanAddress:
Glen Rock, NJ, US
Name:
NAGARATHNAM, DhanapalanAddress:
Bethany, CT, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
909315 PDate:
30.3.2007Country:
US
Number:
982309 PDate:
24.10.2007Country:
US
Number:
53015Date:
21.3.2008Country:
US
Supplementary protection
SPC number:
SPC104
Classification
Categories:
A61K 31/7064, A61K 31/7076
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 3.3.2015
Expires: 25.3.2016
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 1.3.2016
Expires: 25.3.2017
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 2.3.2017
Expires: 25.3.2018
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 2.3.2018
Expires: 25.3.2019
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 4.3.2019
Expires: 25.3.2020
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 3.3.2020
Expires: 25.3.2021
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 8.2.2021
Expires: 25.3.2022
Payer: Árnason Faktor ehf.
Number: 15
Paid: 8.2.2022
Expires: 25.3.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 8.2.2023
Expires: 25.3.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 14.2.2024
Expires: 25.3.2025
Payer: Árnason Faktor ehf.
Number: 18
Paid: 14.2.2025
Expires: 25.3.2026
Payer: Árnason Faktor ehf.
Number: 19
Paid: 12.3.2026
Expires: 25.3.2027
Payer: Árnason Faktor ehf.